Nature Biotechnology
hideNature Biotechnology (Nat Biotechnol; ISSN 1087-0156) is an academic journal covering the science and business of biotechnology.
Nature Biotechnology is a continuation of Bio/technology (Biotechnology (NY); ISSN 0733-222X), which was founded in 1983 and renamed in 1996. It is published monthly by the Nature Publishing Group, a division of Macmillan Publishers Ltd. Like other Nature journals, there is no external Editorial Board; editorial decisions are made by an in-house team, although peer review by external expert referees forms a part of the review process.
Its 2005 impact factor was 22.7, making it the highest cited research journal in the category of biotechnology and applied microbiology, and one of the 20 most highly cited scientific journals. In comparison, the impact factors of general science journals Science and Nature for the same period were 30.927 and 29.273, respectively.
The current editor of Nature Biotechnology is Andrew Marshall. The founding editor of Bio/technology was Christopher Edwards.
For more information about Nature Biotechnology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with nature biotechnology
New discovery allows scientists for the first time to experimentally annotate genomes
Nov 09, 2009 |
5 / 5 (6) |
0
Over the last 20 years, the sequencing of the human genome, along with related organisms, has represented one of the largest scientific endeavors in the history of mankind. The information collected from genome ...
Pandemic flu can infect cells deep in the lungs, says new research
Sep 10, 2009 |
3.7 / 5 (3) |
1
(PhysOrg.com) -- Pandemic swine flu can infect cells deeper in the lungs than seasonal flu can, according to a new study published today in Nature Biotechnology. The researchers, from Imperial College London ...
Scientists improve delivery of cancer-fighting molecules
Aug 27, 2009 |
not rated yet |
0
Small interfering RNA (siRNA), a type of genetic material, can block potentially harmful activity in cells, such as tumor cell growth. But delivering siRNA successfully to specific cells without adversely ...
Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer
Aug 16, 2009 |
5 / 5 (2) |
0
A study published in this week's online issue of Nature Biotechnology, demonstrates a unique and highly sensitive method for detecting methylation-associated cancers.
Technique enables efficient gene splicing in human embryonic stem cells
Aug 13, 2009 |
5 / 5 (1) |
0
A novel technique allows researchers to efficiently and precisely modify or introduce genes into the genomes of human embryonic stem cells (ESCs) and induced pluripotent stem (iPS) cells, according to Whitehead scientists. ...
Launch of the first standard graphical notation for biology
Aug 11, 2009 |
2.5 / 5 (2) |
0
Researchers at the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and their colleagues in 30 labs worldwide have released a new set of standards for graphically representing biological ...
Professor sequences his entire genome at low cost, with small team
Aug 10, 2009 |
4.8 / 5 (13) |
0
(PhysOrg.com) -- The first few times that scientists mapped out all the DNA in a human being in 2001, each effort cost hundreds of millions of dollars and involved more than 250 people. Even last year, when ...
Two lines account for most human embryonic stem cell research
Aug 07, 2009 |
5 / 5 (1) |
0
For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis ...
Exploring standards to advance microbial genomics
Jul 10, 2009 |
not rated yet |
0
Microbes contribute to manifold human endeavors ranging from bioenergy to agriculture to medicine. Moreover, they make the Earth's biogeochemical cycles go round, a prerequisite for all life on the planet. ...
Study: H1N1 flu virus ill-suited for rapid transmission, but new strain bears watching, could mutate
Jul 02, 2009 |
4.6 / 5 (5) |
2
A team from MIT and the Centers for Disease Control and Prevention has found a genetic explanation for why the new H1N1 "swine flu" virus has spread from person to person less effectively than other flu viruses.
Anti-biotech groups obstruct forest biotechnology
Jun 30, 2009 |
3.7 / 5 (7) |
5
The potential of forest biotechnology to help address significant social and environmental issues is being "strangled at birth" by the rigid opposition of some groups and regulations that effectively preclude ...
New biomarker method could increase the number of diagnostic tests for cancer
Jun 29, 2009 |
not rated yet |
0
A team of researchers, including several from UCSF, has demonstrated that a new method for detecting and quantifying protein biomarkers in body fluids may ultimately make it possible to screen multiple biomarkers in hundreds ...
Hi-tech 'Trojan horse' can kill cancer cells: researchers
Nanotechnology / Bio & Medicine
Jun 29, 2009 |
4.7 / 5 (12) |
7
Australian researchers are set to begin human trials of a tiny nano-cell that acts as a "Trojan horse" against cancer cells, a breakthrough they say may curb the need for debilitating chemotherapy.
Small molecules might block mutant protein production in Huntington's disease
May 03, 2009 |
5 / 5 (2) |
0
Molecules that selectively interfere with protein production can stop human cells from making the abnormal molecules that cause Huntington's disease, researchers at UT Southwestern Medical Center have found.
New Method Gives Regenerative Medicine a Boost
Apr 22, 2009 |
5 / 5 (5) |
0
(PhysOrg.com) -- Bioengineers at UC San Diego have developed a breakthrough method for sequencing-based methylation profiling, which could help fuel personalized regenerative medicine and even lead to more ...
